Latest stories on PLRZ
Polyrizon Shareholders Approve New Executive Compensation Policy on July 13, 2026
TipRanks50 · neutralgeneral
Polyrizon Clears Key Safety Milestone for NASARIX Allergy Nasal Spray
TipRanks63 · neutralproduct/pr
Polyrizon shares climb after NASARIX passes key biocompatibility testing (PLRZ)
InvestorsHub63 · neutralproduct/pr
PLRZ Advances Toward Human Trials as NASARIX Clears All Biocompatibility Hurdles
MarketChameleon67 · bullishproduct/pr
Polyrizon Wins Central IRB Nod for First NASARIX Allergy Blocker Trial
TipRanks63 · neutralproduct/pr
Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical Trial | PLRZ Stock News
StockTitan63 · neutralproduct/pr
Polyrizon Announces U.S. Publication of Mucoadhesive Nasal Drug Delivery Patent
TipRanks56 · neutralproduct/pr
Polyrizon receives U.S. patent publication notice for nasal drug delivery platform
Seeking Alpha63 · neutralproduct/pr
Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform | PLRZ Stock News
StockTitan63 · neutralproduct/pr
Polyrizon Launches Key Human Study to Advance NASARIX Allergy Blocker Toward FDA Pathway
TipRanks63 · neutralproduct/pr
Polyrizon Wins European Patent Publication for Mucoadhesive Nasal Drug Delivery Platform
TipRanks63 · neutralproduct/pr
Polyrizon Secures Three Key U.S. Sites for NASARIX Allergy Trial
TipRanks63 · neutralproduct/pr
Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial | PLRZ Stock News
StockTitan67 · bullishproduct/pr
Polyrizon Extends Exclusivity on Proposed 51% Acquisition of Arrow Aviation
TipRanks56 · neutralm&a
Polyrizon Appoints Veteran Entrepreneur Ami Oren to Board of Directors
TipRanks56 · neutralgeneral
Pulse Equity: Emerging Outbreaks - Polyrizon's Approach to Broad and Rapidly Deployable Protection
PR Newswire56 · neutralproduct/pr